GRDX — GridAI Technologies Share News
0.000.00%
Last trade - 00:00- $39.97m
- $45.06m
- $0.04m
Brief: IBN Announces Latest Episode Of The Techmediawire Podcast Featuring Marshall Chapin, CEO Of Grid Ai Corp.
Brief: Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately - SEC Filing
Brief: Entero Therapeutics Inc - Now Offering 15.2 Million Shares Of Common Stock
Brief: Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement
Brief: Entero Therapeutics Secures $2 Million Revolving Loan Appoints Three New Board Members
Brief: Entero Therapeutics Says Immunogenx Received Notice Of Default, Demand For Payment Relating To Credit Agreement
Entero Therapeutics Inc expected to post a loss of 41 cents a share - Earnings Preview
Brief: Entero Therapeutics Announces Proposed Reverse Merger With Journey Therapeutics
Entero Therapeutics Inc expected to post a loss of 32 cents a share - Earnings Preview
Entero Therapeutics Inc reports results for the quarter ended in June 30 - Earnings Summary
Entero Therapeutics Inc expected to post a loss of $1.55 a share - Earnings Preview
Entero Therapeutics Inc expected to post a loss of $1.55 a share - Earnings Preview
Entero Therapeutics Inc expected to post a loss of $1.55 a share - Earnings Preview
Brief: Entero Therapeutics Receives Non-Compliance Notice From Nasdaq
Entero Therapeutics Inc expected to post a loss of $1.55 a share - Earnings Preview
Entero Therapeutics Inc expected to post a loss of $1.55 a share - Earnings Preview
Entero Therapeutics Inc expected to post a loss of $1.55 a share - Earnings Preview
Brief: Entero Therapeutics Says ImmunogenX Received Notice Of Default And Acceleration Relating To Credit Agreement
Brief: Entero Therapeutics Files For Shelf Of Up To 3.5 Mln Shares By Selling Stockholders